VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN
UNII TU8J357395

Substance Identification & Data

This profile provides standardized clinical and technical data for Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TU8J357395.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TU8J357395

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

TU8J357395

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C173552

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.